Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
This study has been completed.
Study NCT00430534   Information provided by Henogen

First Received on February 1, 2007.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epstein Barr Virus (EBV) Infection
Interventions listed in this trial
EBV vaccine (268664)
Sponsors listed in this trial
Henogen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services